Arginase II polymorphisms modify the hypotensive responses to propofol by affecting nitric oxide bioavailability.
Gustavo H Oliveira-PaulaFernanda Borchers Coeli-LacchiniLetícia Perticarrara FerezinGraziele C FerreiraLucas C PinheiroWaynice N Paula-GarciaLuis V GarciaJose E Tanus-SantosRiccardo LacchiniPublished in: European journal of clinical pharmacology (2021)
NCT02442232.